Teva Pharmaceutical Industries Ltd. and Barr Pharmaceuticals, Inc. announced recently that they have signed a definitive agreement under which Teva will acquire Barr, the fourth largest generic drug company worldwide.
129266
Teva to acquire Barr
79889
Merck buys drug rival Schering-Plough
164000
Ligand Pharmaceuticals and Neurogen amend merger agreement
88874
InBev completes acquisition of Anheuser-Busch
125008
Bausch + Lomb to acquire Ista Pharmaceuticals
16623
Checkpoint Systems announces definitive agreement to acquire Shore to Shore
81028
Arkema announces the acquisition by
137115
Grupo Lala acquires National Dairy
90120
3M completes acquisition of
88639
ICON selected as Pfizer strategic partner
118945
Sanofi-Aventis completes acquisition of Chattem
41320
LabCorp strikes deal for Alzheimer's disease diagnostic
28286
DuPont successfully completes tender offer for
170566
Celgene to buy Abraxis BioScience for $2.9 billion
17468
Pernix Therapeutics acquires antibiotic Cedax
103941
Valeant Pharmaceuticals acquires DermaTech
119899
AVI Biopharma secures increased funding of approximately $4.0 million